U.S. Nutrigenomics Market Size, Share, Trends, Industry Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research, Others), By Product, By Technique, By End Use

Description

List of Tables

The U.S. nutrigenomics market size is expected to reach USD 934.23 million by 2034, according to a new study by Polaris Market Research. The report "U.S. Nutrigenomics Market Size, Share, Trends, Industry Analysis Report By Application (Obesity, Cardiovascular Diseases, Cancer Research, Others), By Product, By Technique, By End Use - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The U.S. nutrigenomics market is a specialized field that explores the intricate relationship between an individual's genetic makeup, their diet, and overall health. It focuses on how nutrients and bioactive food compounds interact with genes to influence health outcomes and disease susceptibility. The goal is to provide personalized nutritional recommendations and interventions based on a person's unique genetic profile, moving beyond a one-size-fits-all approach to diet and wellness. This involves genetic analysis for variations to understand how they affect nutrient absorption, metabolism, and response to specific foods, ultimately aiming to optimize health and prevent chronic diseases.

The U.S. nutrigenomics market is experiencing significant growth, driven by a rising consumer interest in personalized health and wellness. People are increasingly seeking tailored solutions that consider their individual biological differences, rather than relying on generic dietary advice. This demand is further fueled by the increasing prevalence of chronic diseases such as obesity, diabetes, and cardiovascular conditions, where diet plays a crucial role in both prevention and management. Advances in genetic testing technologies are making it easier and more affordable to access genetic information, contributing to the market's expansion. The market also sees continuous innovation in product offerings, from genetic testing kits to personalized dietary services, reflecting a dynamic landscape focused on translating genetic insights into actionable health strategies.

U.S. Nutrigenomics Market Report Highlights:

By application, the obesity application segment held the largest share in 2024. This is driven by the widespread and increasing prevalence of obesity across the U.S., leading to a strong consumer demand for personalized and effective weight management strategies that consider individual genetic variations.

By product, the reagents and kits segment held a larger share in 2024. These products are fundamental to performing genetic analysis, providing the necessary tools for extracting and preparing DNA samples, and are a crucial first step for any nutrigenomic study or personalized dietary recommendation.

By technique, the saliva collection segment held the largest share in 2024. Its noninvasive nature and ease of use, allowing for convenient at-home sample collection, have made it the preferred method for widespread genetic testing and accessibility for consumers.

By end use, the hospitals and clinics segment held the largest share in 2024. These traditional healthcare settings provide a trusted environment for patients to receive personalized nutrition advice, integrating genetic insights with comprehensive medical histories and professional guidance.

A few key players in the market include Nutrigenomix, 23andMe, DNAfit (Prenetics Global Limited), GX Sciences (Fagron), Metagenics, Inc., Xcode Life, Vitagene, Mapmygenome, Gini Health, and The Gene Box.

Polaris Market Research has segmented the U.S. nutrigenomics market report on the basis of application, product, technique, and end use:

By Application Outlook (Revenue - USD Million, 2020-2034)

Obesity

Cardiovascular Diseases

Cancer Research

Others

By Product Outlook (Revenue - USD Million, 2020-2034)

Reagents & Kits

Services

By Technique Outlook (Revenue - USD Million, 2020-2034)

Saliva

Buccal Swab

Blood

By End Use Outlook (Revenue - USD Million, 2020-2034)

Hospitals & Clinics

Others

Product Code: PM5959

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. U.S. Nutrigenomics Market Insights

4.1. U.S. Nutrigenomics Market - Market Snapshot
4.2. U.S. Nutrigenomics Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Consumer Interest in Personalized Health
  - 4.2.1.2. Increasing Prevalence of Chronic Diseases
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of genomic testing
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. U.S. Nutrigenomics Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. U.S. Nutrigenomics Market, by Application

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Nutrigenomics Market, by Application, 2020-2034 (USD Million)
5.3. Obesity
- 5.3.1. U.S. Nutrigenomics Market, by Obesity, by Region, 2020-2034 (USD Million)
5.4. Cardiovascular Diseases
- 5.4.1. U.S. Nutrigenomics Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Million)
5.5. Cancer Research
- 5.5.1. U.S. Nutrigenomics Market, by Cancer Research, by Region, 2020-2034 (USD Million)
5.6. Others
- 5.6.1. U.S. Nutrigenomics Market, by Others, by Region, 2020-2034 (USD Million)

6. U.S. Nutrigenomics Market, by Product

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Nutrigenomics Market, by Product, 2020-2034 (USD Million)
6.3. Reagents & Kits
- 6.3.1. U.S. Nutrigenomics Market, by Reagents & Kits, by Region, 2020-2034 (USD Million)
6.4. Services
- 6.4.1. U.S. Nutrigenomics Market, by Services, by Region, 2020-2034 (USD Million)

7. U.S. Nutrigenomics Market, by Technique

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Nutrigenomics Market, by Technique, 2020-2034 (USD Million)
7.3. Saliva
- 7.3.1. U.S. Nutrigenomics Market, by Saliva, by Region, 2020-2034 (USD Million)
7.4. Buccal Swab
- 7.4.1. U.S. Nutrigenomics Market, by Buccal Swab, by Region, 2020-2034 (USD Million)
7.5. Blood
- 7.5.1. U.S. Nutrigenomics Market, by Blood, by Region, 2020-2034 (USD Million)

8. U.S. Nutrigenomics Market, by End Use

8.1. Key Findings
8.2. Introduction
- 8.2.1. U.S. Nutrigenomics Market, by End Use, 2020-2034 (USD Million)
8.3. Hospitals & Clinics
- 8.3.1. U.S. Nutrigenomics Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Million)
8.4. Others
- 8.4.1. U.S. Nutrigenomics Market, by Others, by Region, 2020-2034 (USD Million)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. 23andMe
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. DNAfit (Prenetics Global Limited)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. Gini Health
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. GX Sciences (Fagron)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Mapmygenome
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Metagenics, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Nutrigenomix
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. The Gene Box
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Vitagene
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Xcode Life
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development